Nuzenio

Obesity Drug Trial

Obesity Drug Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Eli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOXLiveNOW from FOX · Fri, 07 Aug 2026 15:20:40 GMTNeurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - PluangPluang · Fri, 07 Aug 2026 12:49:32 GMTNTUH GLP-1 drug study points to drop in obesity-linked cancer risk - Taipei TimesTaipei Times · Thu, 06 Aug 2026 16:00:00 GMTLilly Expands Retatrutide Access Amid Doctor Pushback - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 20:37:18 GMTOzempic May Help You Eat Less Even When Hunger Returns, New Clinical Trial Finds - Black DoctorBlack Doctor · Wed, 05 Aug 2026 14:00:00 GMTRM-718 shows 11.6% BMI reduction in acquired hypothalamic obesity trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 07:37:44 GMTD&D Pharmatech sinks as Pfizer halts Metsera obesity drug trial in Korea - CHOSUNBIZ - ChosunbizChosunbiz · Wed, 05 Aug 2026 00:25:00 GMTEli Lilly to Offer Experimental GLP-1 Retatrutide for Compassionate Use — Who Qualifies? - Everyday HealthEveryday Health · Wed, 05 Aug 2026 00:21:28 GMT

Timeline

Fri, 07 Aug 2026 15:20:40 GMTEli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOX
Fri, 07 Aug 2026 12:49:32 GMTNeurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - Pluang
Thu, 06 Aug 2026 16:00:00 GMTNTUH GLP-1 drug study points to drop in obesity-linked cancer risk - Taipei Times
Wed, 05 Aug 2026 20:37:18 GMTLilly Expands Retatrutide Access Amid Doctor Pushback - The American Journal of Managed Care
Wed, 05 Aug 2026 14:00:00 GMTOzempic May Help You Eat Less Even When Hunger Returns, New Clinical Trial Finds - Black Doctor
Wed, 05 Aug 2026 07:37:44 GMTRM-718 shows 11.6% BMI reduction in acquired hypothalamic obesity trial - The Clinical Trial Vanguard

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obesity Drug Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.